Vascular pentraxin 3 controls arterial thrombosis by targeting collagen and fibrinogen induced platelets aggregation

QR Code

Vascular pentraxin 3 controls arterial thrombosis by targeting collagen and fibrinogen induced platelets aggregation

© 2016 The Authors. Aim: The long pentraxin PTX3 plays a non-redundant role during acute myocardial infarction, atherosclerosis and in the orchestration of tissue repair and remodeling during vascular injury, clotting and fibrin deposition. The aim of this work is to investigate the molecular mechan...

Full description

Bibliographic Details
Main Authors:	Bonacina, F., Barbieri, S., Cutuli, L., Amadio, P., Doni, A., Sironi, M., Tartari, S., Mantovani, A., Bottazzi, B., Garlanda, C., Tremoli, E., Catapano, A., Norata, Giuseppe
Format:	Journal Article
Published:	Elsevier BV 2016
Online Access:	http://hdl.handle.net/20.500.11937/56147

Similar Items

Pentraxins and atherosclerosis
by: Barbati, E., et al.
Published: (2014)

Long pentraxin 3: Experimental and clinical relevance in cardiovascular diseases
by: Bonacina, F., et al.
Published: (2013)

THE CLASS II PHOSPHOINOSITIDE 3-KINASE ISOFORM beta REGULATES PLATELET FUNCTION AND ARTERIAL THROMBOSIS IN MICE
by: Tibolla, G., et al.
Published: (2011)

Pentraxin 3 (PTX3) plasma levels and carotid intima media thickness progression in the general population
by: Baragetti, A., et al.
Published: (2014)

Long pentraxin 3/tumor necrosis factor-stimulated gene-6 interaction a biological rheostat for fibroblast growth factor 2-mediated angiogenesis
by: Leali, D., et al.
Published: (2012)

An acidic microenvironment sets the humoral pattern recognition molecule PTX3 in a tissue repair mode
by: Doni, A., et al.
Published: (2015)

Long pentraxin PTX3 as a prognostic marker of cardiovascular mortality in patients with chronic kidney disease
by: Baragetti, A., et al.
Published: (2017)

The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis
by: Pirillo, A., et al.
Published: (2018)

HDL in innate and adaptive immunity
by: Catapano, A., et al.
Published: (2014)

An Acquired Defect Associated with Abnormal Signaling of the Platelet Collagen Receptor Glycoprotein VI
by: Qiao, J., et al.
Published: (2012)

Differentiation of Staphylococcus aureus and Staphylococcus epidermidis by PCR for the fibrinogen binding protein gene.
by: Babra, Charlene, et al.
Published: (2013)

Leonurine: A new comer in the natural compounds affecting atherosclerosis
by: Norata, Giuseppe, et al.
Published: (2012)

Statins and periodontal inflammation: A pleiotropic effect of statins or a pleiotropic effect of LDL-cholesterol lowering?
by: Norata, Giuseppe, et al.
Published: (2014)

HDL and adaptive immunity: A tale of lipid rafts
by: Norata, Giuseppe, et al.
Published: (2012)

Fibrinogen does not relate to cardiovascular or muscle manifestations in COPD: cross-sectional data from the ERICA study
by: Mohan, Divya, et al.
Published: (2018)

LIM kinase-1 selectively promotes glycoprotein 1b-IX-mediated TXA2 synthesis, platelet activation, and thrombosis
by: Estevez, Brian, et al.
Published: (2013)

Prevalence of classical CD14++/CD16 - But not of intermediate CD14++/CD16 + monocytes in hypoalphalipoproteinemia
by: Sala, F., et al.
Published: (2013)

Constitutive Dimerization of Glycoprotein VI (GPVI) in Resting Platelets Is Essential for Binding to Collagen and Activation in Flowing Blood
by: Jung, S., et al.
Published: (2012)

The CD1d-natural killer T cell axis in atherosclerosis
by: Bondarenko, S., et al.
Published: (2014)

The predictive and diagnostic accuracy of vascular endothelial growth factor and pentraxin-3 in severe dengue
by: Kim, Gary Kuan Low, et al.
Published: (2018)

The Predictive And Diagnostic Accuracy Of Pentraxin-3 And Vascular Endothelial Growth Factor In Severe Dengue
by: Low, Gary Kim Kuan
Published: (2019)

High-density lipoprotein subfractions - What the clinicians need to know
by: Pirillo, A., et al.
Published: (2013)

Postprandial lipemia as a cardiometabolic risk factor
by: Pirillo, A., et al.
Published: (2014)

Vascular inflammation and low-density lipoproteins: Is cholesterol the link? A lesson from the clinical trials
by: Catapano, A., et al.
Published: (2017)

Therapy and clinical trials: Aggressive statin therapy versus combined and emerging approaches
by: Catapano, A., et al.
Published: (2011)

Novel concepts in HDL pharmacology
by: Remaley, A., et al.
Published: (2014)

Niemann-pick C1-like 1 (NPC1L1) inhibition and cardiovascular diseases
by: Pirillo, A., et al.
Published: (2016)

LOX-1, OxLDL, and atherosclerosis
by: Pirillo, A., et al.
Published: (2013)

HDLs, immunity, and atherosclerosis
by: Norata, Giuseppe, et al.
Published: (2011)

Treating high density lipoprotein cholesterol (HDL-C): Quantity versus quality
by: Pirillo, A., et al.
Published: (2013)

HDL in infectious diseases and sepsis
by: Pirillo, A., et al.
Published: (2015)

Targeting Cholesterol in Non-ischemic Heart Failure: A Role for LDLR Gene Therapy?
by: Catapano, A., et al.
Published: (2017)

Strategies for the use of nonstatin therapies
by: Pirillo, A., et al.
Published: (2017)

Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: Patient selection and perspectives
by: Catapano, A., et al.
Published: (2017)

Attenuation of thrombosis by crude rice (Oryza sativa) bran policosanol extract: Ex Vivo platelet aggregation and serum levels of arachidonic acid metabolites
by: Wai, Teng Wong, et al.
Published: (2016)

Arterial thrombosis: Going, gone!
by: Gardiner, E., et al.
Published: (2010)

Targeting PCSK9 for hypercholesterolemia
by: Norata, Giuseppe, et al.
Published: (2014)

Gene silencing approaches for the management of dyslipidaemia
by: Norata, Giuseppe, et al.
Published: (2013)

Statins and skeletal muscles toxicity: From clinical trials to everyday practice
by: Norata, Giuseppe, et al.
Published: (2014)

PCSK9 inhibition for the treatment of hypercholesterolemia: Promises and emerging challenges
by: Norata, Giuseppe, et al.
Published: (2014)

Cannot write session to /tmp/vufind_sessions/sess_oe7ld5l6akhjjfgi1iirkf07hm